A 55-year-old man receiving alpha-interferon and interleukin-2 therapy for renal cell carcinoma presented with seizures and delirium. A CT-scan of the cerebrum did not reveal any disorder. Both alpha-interferon and interleukin-2 were stopped. Treatment with steroids led to complete regression of central nervous system symptomatology. We emphasize the importance of ruling out iatrogenesis in patients treated with alpha-interferon and/or interleukin-2 who display neuropsychiatric symptoms.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
therapy renal
8
renal cell
8
cell carcinoma
8
alpha-interferon interleukin-2
8
delirium interleukin-2
4
alpha-interferon
4
interleukin-2 alpha-interferon
4
alpha-interferon therapy
4
carcinoma 55-year-old
4
55-year-old man
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!